DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 778 filers reported holding DANAHER CORPORATION in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,442,134 | -0.7% | 5,772 | -0.7% | 0.29% | +0.3% |
| Q1 2024 | $1,452,122 | +4.4% | 5,815 | -3.3% | 0.29% | +0.7% |
| Q4 2023 | $1,390,585 | -0.2% | 6,011 | +7.1% | 0.29% | -9.7% |
| Q3 2023 | $1,392,833 | +3.3% | 5,614 | -0.1% | 0.32% | +11.1% |
| Q2 2023 | $1,348,800 | -4.8% | 5,620 | 0.0% | 0.29% | -7.4% |
| Q1 2023 | $1,416,465 | +94837.3% | 5,620 | 0.0% | 0.31% | -6.6% |
| Q4 2022 | $1,492 | -99.9% | 5,620 | -2.6% | 0.33% | -10.5% |
| Q3 2022 | $1,490,000 | -1.1% | 5,770 | -2.9% | 0.37% | +3.6% |
| Q2 2022 | $1,507,000 | -13.6% | 5,945 | 0.0% | 0.36% | -3.7% |
| Q1 2022 | $1,744,000 | -10.8% | 5,945 | 0.0% | 0.37% | -7.0% |
| Q4 2021 | $1,956,000 | +8.8% | 5,945 | 0.0% | 0.40% | +0.5% |
| Q3 2021 | $1,797,000 | +12.6% | 5,945 | 0.0% | 0.40% | +13.3% |
| Q2 2021 | $1,596,000 | +17.8% | 5,945 | -1.2% | 0.35% | +13.1% |
| Q1 2021 | $1,355,000 | +1.3% | 6,020 | 0.0% | 0.31% | -4.6% |
| Q4 2020 | $1,337,000 | -2.5% | 6,020 | -5.5% | 0.33% | -13.0% |
| Q3 2020 | $1,371,000 | +20.8% | 6,370 | -0.8% | 0.38% | +14.6% |
| Q2 2020 | $1,135,000 | +25.3% | 6,420 | -1.8% | 0.33% | +7.9% |
| Q1 2020 | $906,000 | -8.8% | 6,540 | +1.1% | 0.30% | +15.6% |
| Q4 2019 | $993,000 | +5.1% | 6,470 | -1.1% | 0.26% | +0.8% |
| Q3 2019 | $945,000 | +0.3% | 6,542 | -0.8% | 0.26% | -1.9% |
| Q2 2019 | $942,000 | +7.3% | 6,592 | -0.9% | 0.27% | +6.8% |
| Q1 2019 | $878,000 | +28.4% | 6,652 | +0.3% | 0.25% | +16.4% |
| Q4 2018 | $684,000 | -6.4% | 6,630 | -1.5% | 0.21% | +3.9% |
| Q3 2018 | $731,000 | +8.5% | 6,730 | -1.5% | 0.21% | +1.0% |
| Q2 2018 | $674,000 | +0.7% | 6,830 | 0.0% | 0.20% | +0.5% |
| Q1 2018 | $669,000 | +5.7% | 6,830 | 0.0% | 0.20% | +8.0% |
| Q4 2017 | $633,000 | +8.0% | 6,830 | 0.0% | 0.19% | -5.1% |
| Q3 2017 | $586,000 | +1.7% | 6,830 | 0.0% | 0.20% | -2.9% |
| Q2 2017 | $576,000 | -1.4% | 6,830 | 0.0% | 0.20% | -0.5% |
| Q1 2017 | $584,000 | +9.8% | 6,830 | 0.0% | 0.20% | +12.0% |
| Q4 2016 | $532,000 | -0.6% | 6,830 | 0.0% | 0.18% | -0.5% |
| Q3 2016 | $535,000 | -32.4% | 6,830 | -12.8% | 0.18% | -28.7% |
| Q2 2016 | $791,000 | +15.6% | 7,830 | +8.5% | 0.26% | +17.8% |
| Q1 2016 | $684,000 | -6.8% | 7,215 | -8.6% | 0.22% | -11.3% |
| Q4 2015 | $734,000 | +17.4% | 7,895 | +7.6% | 0.25% | +9.8% |
| Q3 2015 | $625,000 | -0.5% | 7,335 | 0.0% | 0.22% | +7.7% |
| Q2 2015 | $628,000 | +0.8% | 7,335 | 0.0% | 0.21% | +0.5% |
| Q1 2015 | $623,000 | -1.0% | 7,335 | +122150.0% | 0.21% | +0.5% |
| Q4 2014 | $629,000 | +16.3% | 6 | -99.9% | 0.21% | +12.5% |
| Q3 2014 | $541,000 | +20.0% | 7,125 | +24.5% | 0.18% | +20.3% |
| Q2 2014 | $451,000 | +4.9% | 5,725 | -0.1% | 0.15% | +2.0% |
| Q1 2014 | $430,000 | -9.1% | 5,730 | -6.5% | 0.15% | -10.2% |
| Q4 2013 | $473,000 | +11.3% | 6,130 | 0.0% | 0.17% | +3.1% |
| Q3 2013 | $425,000 | +9.5% | 6,130 | 0.0% | 0.16% | +7.3% |
| Q2 2013 | $388,000 | – | 6,130 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |